Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina

ConclusionsWe found an incidence density of breakthrough COVID-19 infection of 3.5  × 10.000 patients/day (95% CI 2.3–6.7) after vaccination in Argentina.
Source: Neurological Sciences - Category: Neurology Source Type: research